Safety and immunogenicity of the ChAdOx1–MVA-vectored conserved mosaic HIVconsvX candidate T-cell vaccines in HIV-CORE 005.2, an open-label, dose-escalation, first-in-human, phase 1 trial in adults living without HIV-1 in the UK
Titel:
Safety and immunogenicity of the ChAdOx1–MVA-vectored conserved mosaic HIVconsvX candidate T-cell vaccines in HIV-CORE 005.2, an open-label, dose-escalation, first-in-human, phase 1 trial in adults living without HIV-1 in the UK
Auteur:
Borthwick, Nicola Fernandez, Natalia Hayes, Peter J Wee, Edmund G-T Akis Yildirim, Belkis M Baines, Andrea Baker, Megan Byard, Nicholas Conway, Oliver Glaze, Molly Jenkin, Daniel Larkworthy, Colin Luciw, Michael Platt, Abigail Poulton, Ian Thomas, Merin Quaddy, Jack Watson, Marion Crook, Alison Cicconi, Paola Hanke, Tomáš